| 1 |
Zhang W, Ma J, Wang S, Huang T, Xia M. Tranilast attenuates neuropathic pain during type-2 diabetes by inhibiting hypoxia-induced pro-inflammatory cytokines in Zucker diabetic fatty rat model. Arch Physiol Biochem 2020;:1-14. [PMID: 33307841 DOI: 10.1080/13813455.2020.1854309] [Reference Citation Analysis]
|
| 2 |
Chen Y, Huang M, Yan Y, He D. Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis. Bioengineered 2021;12:8447-56. [PMID: 34663163 DOI: 10.1080/21655979.2021.1982322] [Reference Citation Analysis]
|
| 3 |
Lu J, Chen C, Deng X, Mak MS, Zhu Z, He X, Liang J, Maddili SK, Tsim KWK, Han Y, Pi R. Design, Synthesis, and Biological Evaluation of Novel Multifunctional Rolipram-Tranilast Hybrids As Potential Treatment for Traumatic Brain Injury. ACS Chem Neurosci 2020;11:2348-60. [PMID: 32644771 DOI: 10.1021/acschemneuro.0c00339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 4 |
Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. [PMID: 32754159 DOI: 10.3389/fimmu.2020.01648] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 56.0] [Reference Citation Analysis]
|
| 5 |
Bai R, Lang Y, Shao J, Deng Y, Refuhati R, Cui L. The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets. ASN Neuro 2021;13:17590914211018100. [PMID: 34053242 DOI: 10.1177/17590914211018100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Hao C, Chen S. Knockdown of lncRNA TTTY15 alleviates ischemia/reperfusion-induced inflammation and apoptosis of PC12 cells by targeting miR-766-5p. Exp Ther Med 2021;21:511. [PMID: 33791020 DOI: 10.3892/etm.2021.9942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Makled MN, Said E. Tranilast abrogates cisplatin-induced testicular and epididymal injuries: An insight into its modulatory impact on apoptosis/proliferation. J Biochem Mol Toxicol 2021;35:e22817. [PMID: 34047436 DOI: 10.1002/jbt.22817] [Reference Citation Analysis]
|
| 8 |
Saeedi-Boroujeni A, Mahmoudian-Sani MR, Nashibi R, Houshmandfar S, Tahmaseby Gandomkari S, Khodadadi A. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacol Immunotoxicol 2021;43:247-58. [PMID: 34015982 DOI: 10.1080/08923973.2021.1925293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
Zhang Y. Mechanism of neuroprotective effect of stevioside on cerebral ischemia-reperfusion injury via PPAR-γ activation. Immunopharmacol Immunotoxicol 2021;43:704-12. [PMID: 34448677 DOI: 10.1080/08923973.2021.1966034] [Reference Citation Analysis]
|
| 10 |
Mannan A, Garg N, Singh TG, Kang HK. Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury. Neurochem Res 2021. [PMID: 34282491 DOI: 10.1007/s11064-021-03402-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
